GoodRx (GDRX) Environmental, Social & Governance (ESG) Data

Employees

Data from SEC filings

Employee count

ESG framework mentions

In last year of SEC filings

Sustainability Accounting Standards Board (SASB)

No mentions

Global Reporting Initiative (GRI)

No mentions

Task Force on Climate-related Financial Disclosures (TCFD)

No mentions

UN Sustainable Development Goals (SDGs)

No mentions

ESG term mentions

In last year of SEC filings

Air Climate Ecosystem Environment Environmental Green Materials Nature Offset Package Pandemic Waste Access Affordability African American Asian Benefits Black California Consumer Privacy Act Charitable Charity Community Consumer Sentiment Culture Customer Cyber Cybersecurity Data Privacy Data Security Death Demographic Disability Diversity Employee Engagement Ethnicity Gender Health Care Healthcare Hire Hiring Hispanic Human Resources Incident Latinx LGBTQ Minority Parental Leave Pay for Performance Perquisites Philanthropic Philanthropy Privacy Recruit Reimbursement Retention Retirement Safety Satisfaction Skill Skilled Skills Social Society Stakeholder Supplier Supply Chain Management Talent Training Women Workforce Activist Assessment Assurance Attorney General Attorneys General Audit Board Oversight Bonus Chronic Class Action Lawsuit Classified Commitment Conflict of Interest Corporate Governance Corporate Purpose Department of Dual-class Ethics Executive Compensation Expert Fraud Goals Governance Hedging Incentive Incentivize Independence Independent Independent Chair Innovate Innovation Investigation Lawsuit Leadership Litigant Litigation Long-term Majority Mission Oversee Oversight Perquisite Plaintiff Pledging Proxy Contest Purpose Reputation Reputational Research and Development Responsibility Responsible Special Meeting Strategy Sustainability Sustainable Targets Tax Transparency Transparent Voting Rights

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

On June 10, 2021, GoodRx Holdings, Inc. (the “Company”) held its Annual Meeting of Stockholders. Holders of the Company’s Class A common stock were entitled to one vote per share held as of the close of business on April 16, 2021 (the “Record Date”) and holders of the Company’s Class B common stock were entitled to ten votes per share held as of the Record Date. A total of 50,176,842 shares of the Company’s Class A common stock and 319,339,392 shares of the Company’s Class B common stock were present in person or represented by proxy at the meeting, representing approximately 98.7% percent of the combined voting power of the Company’s Class A and Class B common stock as of the Record Date. The following are the voting results for the proposals considered and voted upon at the meeting, each of which were described in the Company’s Definitive Proxy Statement filed with the Securities and Exchange Commission on April 27, 2021.